Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma

Dirk Schadendorf; Mayur M. Amonkar; Daniil Stroyakovskiy; Evgeny Levchenko; Helen Gogas; Filippo de Braud; Jean-Jacques Grob; Igor Bondarenko; Claus Garbe; Celeste Lebbe; James Larkin; Vanna Chiarion-Sileni; Michael Millward; Ana Arance; Mario Mandalà; Keith T. Flaherty; Paul Nathan; Antoni Ribas; Caroline Robert; Michelle Casey; Douglas J. DeMarini; Jhangir G. Irani; Gursel Aktan; Georgina V. Long

doi:10.1016/j.ejca.2015.03.004

Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma

European Journal of Cancer ◽

10.1016/j.ejca.2015.03.004 ◽

2015 ◽

Vol 51 (7) ◽

pp. 833-840 ◽

Cited By ~ 45

Author(s):

Dirk Schadendorf ◽

Mayur M. Amonkar ◽

Daniil Stroyakovskiy ◽

Evgeny Levchenko ◽

Helen Gogas ◽

...

Keyword(s):

Quality Of Life ◽

Metastatic Melanoma ◽

Phase Iii ◽

Health Related Quality ◽

Life Impact ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text

Health-Related Quality of Life in Patients with Advanced Metastatic Melanoma: Results of a Randomized Phase III Study Comparing Temozolomide with Dacarbazine

Cancer Investigation ◽

10.1081/cnv-120025084 ◽

2003 ◽

Vol 21 (6) ◽

pp. 821-829 ◽

Cited By ~ 35

Author(s):

Gwendoline M. Kiebert ◽

Deborah L. Jonas ◽

Mark R. Middleton

Keyword(s):

Quality Of Life ◽

Metastatic Melanoma ◽

Phase Iii ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text

Lux-Lung 3: Symptom and Health-Related Quality of Life Results from a Randomized Phase III Study in 1st-Line Advanced NSCLC Patients Harbouring EGFR Mutations

Annals of Oncology ◽

10.1016/s0923-7534(20)33860-6 ◽

2012 ◽

Vol 23 ◽

pp. ix402

Author(s):

L.V. Sequist ◽

M. Schuler ◽

N. Yamamoto ◽

K.J. O'Byrne ◽

V. Hirsh ◽

...

Keyword(s):

Quality Of Life ◽

Advanced Nsclc ◽

Phase Iii ◽

Egfr Mutations ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Phase Iii Study ◽

Nsclc Patients

Download Full-text

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study

Health and Quality of Life Outcomes ◽

10.1186/1477-7525-6-75 ◽

2008 ◽

Vol 6 (1) ◽

pp. 75 ◽

Cited By ~ 29

Author(s):

Dennis A Revicki ◽

Alan Menter ◽

Steven Feldman ◽

Miriam Kimel ◽

Neesha Harnam ◽

...

Keyword(s):

Quality Of Life ◽

United States ◽

The United States ◽

Phase Iii ◽

Health Related Quality ◽

Randomized Controlled ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text

1305P Health-related quality of life (HRQoL) in a phase III study of first-line brigatinib (BRG) vs crizotinib (CRZ) in NSCLC: Updated results from ALTA-1L

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1619 ◽

2020 ◽

Vol 31 ◽

pp. S844

Author(s):

M.R. Garcia Campelo ◽

Y. Zhu ◽

H.M. Lin ◽

M. Pérol ◽

M. Jahanzeb ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Health Related Quality ◽

First Line ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-2860 ◽

2019 ◽

Vol 25 (19) ◽

pp. 5759-5765 ◽

Cited By ~ 3

Author(s):

Guillaume Eberst ◽

Amélie Anota ◽

Arnaud Scherpereel ◽

Julien Mazieres ◽

Jacques Margery ◽

...

Keyword(s):

Quality Of Life ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Health Related Quality ◽

Phase Iii Trial ◽

Life Impact ◽

Related Quality ◽

Health Related

Download Full-text

Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.12177 ◽

2013 ◽

Vol 28 (6) ◽

pp. 790-798 ◽

Cited By ~ 17

Author(s):

K.A. Papp ◽

M. Sundaram ◽

Y. Bao ◽

D.A. Williams ◽

Y. Gu ◽

...

Keyword(s):

Quality Of Life ◽

Work Productivity ◽

Severe Psoriasis ◽

Phase Iii ◽

Health Related Quality ◽

Activity Impairment ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text

Health-related quality of life (HRQL) in women with HER2-overexpressing metastatic breast cancer (MBC) in a phase III study of Herceptin (R) plus chemotherapy versus chemotherapy alone

European Journal of Cancer ◽

10.1016/s0959-8049(99)81692-x ◽

1999 ◽

Vol 35 ◽

pp. S318 ◽

Cited By ~ 3

Author(s):

J. Baselga ◽

M. Kerrigan ◽

M. Burchmore ◽

M. Ash

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text

32 LUX-Lung 3: Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutations

Lung Cancer ◽

10.1016/s0169-5002(13)70032-1 ◽

2013 ◽

Vol 79 ◽

pp. S11 ◽

Cited By ~ 1

Author(s):

K.J. O'Byrne ◽

L.V. Sequist ◽

M. Schuler ◽

N. Yamamoto ◽

V. Hirsh ◽

...

Keyword(s):

Quality Of Life ◽

Advanced Nsclc ◽

Phase Iii ◽

Egfr Mutations ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Phase Iii Study ◽

Nsclc Patients

Download Full-text

Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study

European Journal of Cancer ◽

10.1016/j.ejca.2011.06.035 ◽

2012 ◽

Vol 48 (6) ◽

pp. 813-819 ◽

Cited By ~ 20

Author(s):

Morten Brændengen ◽

Kjell M. Tveit ◽

Marianne J. Hjermstad ◽

Hemming Johansson ◽

Åke Berglund ◽

...

Keyword(s):

Quality Of Life ◽

Multimodal Treatment ◽

Phase Iii ◽

Long Term Results ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text

Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study

Annals of Oncology ◽

10.1016/j.annonc.2020.04.014 ◽

2020 ◽

Vol 31 (8) ◽

pp. 1046-1055 ◽

Cited By ~ 1

Author(s):

M. van der Meulen ◽

K. Bakunina ◽

M. Nijland ◽

M.C. Minnema ◽

G. Cull ◽

...

Keyword(s):

Quality Of Life ◽

Central Nervous System ◽

Nervous System ◽

Central Nervous System Lymphoma ◽

Phase Iii ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text